Tour de France

[Frank Pembleton]

Cyclingnews went a little farther and added some analysis-- here's the last paragraph of their story:

The prevalence of asthma in the professional peloton has been the subject of debate for more than a decade. One study before the 1996 Olympics showed that 45% of cyclists had asthma that required medication. While other forms of corticosteroids offer some performance enhancing benefit, inhaled versions such as those found in asthma drugs, and beta-agonists like salbutamol, are not considered to be performance enhancing, and are allowed in competition with a TUE.

http://www.cyclingnews.com/news.php?id=news/2007/jan07/jan19news